|
Age | 67 |
|
Patients with tumors located in the supraorbital notch are scheduled for cranial neurosurgery at an appropriate time | Yes
|
|
American Society of Anesthesiologists (ASA) physical status of I-III | ASA II
|
|
The patient is conscious and cooperative prior to surgery and can provide informed consent | Yes
|
|
known hypersensitivity to local anaesthetics (liposomal bupivacaine, ropivacaine), nonsteroidal anti-inflammatory drugs and opioids (NSAIDs), or opioids | No
|
|
history of chronic headache | No
|
|
severe pulmonary disease, hepatic or renal insufficiency | No
|
|
pre-existing coagulopathy | No
|
|
infection at the block injection sites | No
|
|
significant cognitive impairment | No
|
|
concurrent participation in another interventional clinical trial | No
|
|
refusal to participate | No
|
- Age
- sex
- Body Mass Index (BMI)
- ASA physical status
- HR admission,
- MAP admission,
- Preoperative complication
- tumor characteristics
- Treatment
|
|
次/分 |
mmHg |
|
mL |
|
mL |
mg |
mg |
mL |
mL |
mL |
min |
min |
|
PACU |
|
|
24 hours after surgery |
|
|
48 hours after surgery |
|
|
72 hours after surgery |
|
|
PACU |
|
|
24 hours after surgery |
|
|
48 hours after surgery |
|
|
72 hours after surgery |
|
- Haemodynamic stability
- Total consumption of intraoperative fentanyl and postoperative rescue propacetamol
- Length of hospital stay
- Inflammatory response
- Adverse events
|
skin incision | BPM |
|
skin closure | BPM |
|
head pinning | BPM |
|
skin incision | mmHg |
|
skin closure | mmHg |
|
head pinning | mmHg |
|
Total intraoperative fentanyl consumption | mg |
|
Postoperative dose of propamol | g |
days |
|
CRP | mg/mL |